# Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE)

> **NCT00231270** · PHASE3 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 1300 (—)

## Conditions studied

- Carotid Artery Disease

## Interventions

- **DEVICE:** Cordis Nitinol Stent
- **DEVICE:** PRECISE tapered stent
- **DEVICE:** ANGIOGUARD XP Emboli Capture Guidewire (ECGW)

## Key facts

- **NCT ID:** NCT00231270
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 1300 (—)
- **Last updated:** 2008-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231270, "Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00231270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*